BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22703467)

  • 1. Letter: TPMT - not all that glitters is gold.
    González-Lama Y; Gisbert JP
    Aliment Pharmacol Ther; 2012 Jul; 36(2):208-9; author reply 209-10. PubMed ID: 22703467
    [No Abstract]   [Full Text] [Related]  

  • 2. High TPMT enzyme activity does not explain drug resistance due to preferential 6-methylmercaptopurine production in patients on thiopurine treatment.
    van Egmond R; Chin P; Zhang M; Sies CW; Barclay ML
    Aliment Pharmacol Ther; 2012 May; 35(10):1181-9. PubMed ID: 22486532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thiopurines: an update.
    Coulthard S; Hogarth L
    Invest New Drugs; 2005 Dec; 23(6):523-32. PubMed ID: 16267626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
    Gearry RB; Barclay ML; Roberts RL; Harraway J; Zhang M; Pike LS; George PM; Florkowski CM
    Intern Med J; 2005 Oct; 35(10):580-5. PubMed ID: 16207256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
    Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
    Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why measure thiopurine methyltransferase activity? Direct administration of 6-thioguanine might be the alternative for 6-mercaptopurine or azathioprine.
    de Jong D; Mulder CJ; van Sorge AA
    Gut; 2001 Dec; 49(6):874. PubMed ID: 11758505
    [No Abstract]   [Full Text] [Related]  

  • 7. Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy.
    Dervieux T; Meyer G; Barham R; Matsutani M; Barry M; Boulieu R; Neri B; Seidman E
    Clin Chem; 2005 Nov; 51(11):2074-84. PubMed ID: 16166171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients.
    González-Lama Y; Bermejo F; López-Sanromán A; García-Sánchez V; Esteve M; Cabriada JL; McNicholl AG; Pajares R; Casellas F; Merino O; Carpio D; Vera MI; Muñoz C; Calvo M; Benito LM; Bujanda L; García-Fernández FJ; Ricart E; Ginard D; Velasco M; Carneros JA; Manceñido N; Calvo M; Algaba A; Froilan C; Cara C; Maté J; Abreu L; Gisbert JP;
    Aliment Pharmacol Ther; 2011 Sep; 34(5):544-54. PubMed ID: 21722149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of azathioprine therapy by measuring 6-thioguanine nucleotides and methylated mercaptopurine in renal allograft recipients.
    Bergan S; Rugstad HE; Bentdal O; Sødal G; Hartmann A; Klemetsdal B; Aarbakke J; Stokke O
    Transplant Proc; 1995 Dec; 27(6):3426. PubMed ID: 8540033
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary: tioguanine in the treatment of refractory coeliac disease.
    Mooney PD; Sanders DS; Hadjivassilou M; Lennard L
    Aliment Pharmacol Ther; 2012 Sep; 36(6):594-5; author reply 595. PubMed ID: 22913842
    [No Abstract]   [Full Text] [Related]  

  • 11. Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.
    Wall GC; Muktar H; Effken C; Mahajan PB
    Pharmacotherapy; 2018 Feb; 38(2):259-270. PubMed ID: 29197117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring.
    Caufield M; Tom WL
    J Am Acad Dermatol; 2013 Jan; 68(1):29-35. PubMed ID: 22892285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.
    Reinshagen M; Schütz E; Armstrong VW; Behrens C; von Tirpitz C; Stallmach A; Herfarth H; Stein J; Bias P; Adler G; Shipkova M; Kruis W; Oellerich M; von Ahsen N
    Clin Chem; 2007 Jul; 53(7):1306-14. PubMed ID: 17495015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB; Barclay ML
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state of azathioprine during initiation treatment of pediatric inflammatory bowel disease.
    Pozler O; Chládek J; Malý J; Hroch M; Dědek P; Beránek M; Krásničanová P
    J Crohns Colitis; 2010 Dec; 4(6):623-8. PubMed ID: 21122571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of thiopurine metabolites: a potential analytical bias.
    de Graaf P; de Boer NK; Jharap B; Mulder CJ; van Bodegraven AA; Veldkamp AI
    Clin Chem; 2008 Jan; 54(1):216-8. PubMed ID: 18160731
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center.
    Banerjee S; Bishop WP
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):324-30. PubMed ID: 16954954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay of 6-thioguanine nucleotide, a major metabolite of azathioprine, 6-mercaptopurine and 6-thioguanine, in human red blood cells.
    Lennard L; Maddocks JL
    J Pharm Pharmacol; 1983 Jan; 35(1):15-8. PubMed ID: 6131958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological study.
    Seinen ML; van Asseldonk DP; de Boer NK; Losekoot N; Smid K; Mulder CJ; Bouma G; Peters GJ; van Bodegraven AA
    J Crohns Colitis; 2013 Nov; 7(10):812-9. PubMed ID: 23317929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.